Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acetylcholine receptor antibody
acoustic nerve
acquired immunodeficiency syndrome
advances in neurology
adverse drug reaction
afebrile
agitation
anti GQ1b IgG antibody
antiviral agents
aphasia
areflexia
arteritides
arteritis, temporal
arteritis, temporal, recurrent
arthralgia
ataxia, sensory
atezolizumab
atypical
autoantibodies
autoimmune disease
autonomic dysfunction
B cell lymphoma
brain biopsy
Broca's aphasia
burning paresthesia
cancer associated myopathy
carcinoma
carcinoma of lung
cardiotoxicity
CAT scan, emission, abnormal
cauda equina
cauda equina, enhancement
cauda equina, lesion of
CD19-directed chimeric antigen receptor T-cell therapy
cerebellitis
cerebellitis, autoimmune
cerebral arteries
cerebrospinal fluid, pressure increased
cerebrovascular accident
chemotherapy, CNS treatment and complications with
chorea
coinfection
complications
confusion
confusional state, acute
cranial nerve palsies
cranial neuropathy
cranial neuropathy, multiple
creatine phosphokinase(CPK)elevated
cryptococcal meningitis
cytokine release syndrome
dabrafenib
demyelinating disease
dentate nuclei
dentate nuclei, lesion of
diabetes insipidus
differential diagnosis
diplopia
disorientation
dropped head syndrome
drug abuse
drug induced neurologic disorders
duvalumab
dyspnea
efficacy
electroencephalogram, abnormalities of
electromyogram
encephalitis
encephalitis, autoimmune
encephalitis, viral
encephalopathy
encephalopathy, acute
episodic disorders
extralimbic encephalitis
face, numbness of
facial nerve palsy
fever
Fisher's syndrome
gammaglobulin therapy, intravenous
ganglionitis
glutamic acid decarboxylase, antibody
granulomatous hypophysitis
Guillain Barre syndrome
hallucination
hallucination, auditory
hallucination, visual
headache
hemiparesis
hemiplegia, progressive
hippocampal atrophy
hippocampus, hyperintense
Hodgkin's disease
human herpesvirus 6
hyperactivity
hypercalcemia
iatrogenic neurologic disorders
idiopathic
immune checkpoint inhibitors
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunologic disease
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
incidence
internal carotid artery
intracranial pressure, increased
intracranial pressure, increased, treatment of
ipilimumab
JC virus
leukopenia
levamisole
limb-girdle weakness
limbic encephalitis
limbic system
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma, systemic
melanoma, malignant
memory, impairment of
meningismus
meningitis
meningitis, drug induced
meningoencephalitis
mental status, abnormal
mesial temporal lobe
middle cerebral artery
misdiagnosis
monoclonal antibodies
mortality
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, diffusion weighted
MRI, FLAIR
MRI, optic nerve
multiple organ failure
multiple sclerosis
muscle biopsy
muscle pain
muscle weakness
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myocarditis
myopathy
myopathy, inflammatory
myopathy, necrotizing
myopathy, necrotizing, immune-mediated
myositis
nausea and vomiting
neck weakness
neoplasm, metastatic
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS-treatment of
neurologic complications of, systemic cancer
neurologic complications of, systemic disease
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neuromuscular junction
neuromuscular junction, abnormality of
neuronopathy, sensory
neuroophthalmology
neuropathy
neuropathy, iatrogenic
neuropathy, medication induced
neuropathy, sensory
neurotoxic
nivolumab
ocular motility, disorders of
ophthalmoplegia
opportunistic infection
opportunistic infection, CNS
optic disc edema
optic nerve, enhancement
optic neuritis
optic neuropathy
orthostatic hypotension
papilledema
paraneoplastic ganglionopathy
paresthesias
pembrolizumab
pituitary stalk
pituitary stalk, enlarged
plasmapheresis
pleocytosis of cerebrospinal fluid
polymerase chain reaction, false negative
polyneuropathy, chronic inflammatory demyelinating
precipitating factors
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
pruritus
pseudoathetosis
ptosis
ptosis, bilateral
radiation therapy, CNS treatment and complications with
rechallenge
recurrent
remote effect of cancer on the nervous system
respiratory failure
review article
rhabdomyolysis
risk factors
Romberg's sign
safety
sarcoidosis
sarcoidosis, CNS
seizure
sensory ganglia
sensory ganglia, abnormal
sensory loss
sensory loss, truncal
seronegative
shunt procedure, ventricular
Sjogren's syndrome
speech disorder
speech, slowed
steroid
steroid therapy, CNS treatment and complications with
systemic illness
temporal lobe, lesion
temporal lobe, lesion, bilateral
trametinib
treatment of neurologic disorder
tumor necrosis factor inhibitor
vasculitides
viral infection, CNS
visual acuity, decreased
visual loss
weakness
weakness, fatiguable
white matter disease
word-finding difficulty
workup
Showing articles 350 to 400 of 6580 << Previous Next >>

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011

Autoimmune encephalitis
BMJ 342:d1918, Irani, S.R.,et all, 2011

C-Reactive Protein Level Measurement Improves Mortality Prediction When Added to the Spontaneous Intracerebral Hemorrhage Score
Stroke 42:1230-1236, Napoli, M.D.,et al, 2011

VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Neurology 76:1252-1255, Suleiman, J.,et al, 2011

Bacterial Meningitis in the United States, 1998-2007
NEJM 364:2016-25, Thigpen, M.C.,et al, 2011

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011

Paraneoplastic isolated myelopathy Clinical course and neuroimaging clues
Neurol 76:2089-2095, Flanagan, E.P.,et al, 2011

Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011

Retrospective Analysis of NMDA Receptor Antibodies in Encephalitis of Unknown Origin
Neurol 75:1735-1739, Pr�ss,H.,et al, 2010

Predictors of Neurologic Outcome in Hypothermia After Cardiac Arrest
Ann Neurol 68:907-914, Fugate,J.E.,et al, 2010

Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010

Challenge of the Unknown: A Systematic Review of Acute Encephalitis in Non-Outbreak Situations
Neurol 75:924-932, Granerod,J. et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

An Effective Immunotherapy Regimen for VGKC Antibody-Positive Limbic Encephalitis
JNNP 81:1167-1169, Wong,S.H.,et al, 2010

Atypical Dementia
Lancet 376:656, Cohen-Bittan,J. et al, 2010

Anti-NMDA Receptor Encephalitis Causing Prolonged Nonconvulsive Status Epilepticus
Neurol 75:1480-1482, Johnson,N.,et al, 2010

AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

Clinicopath Conf, Infantile Krabbe Disease
NEJM 362:346-356, Case 3-2010, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

Glucose Transporter-1 Deficiency Syndrome: The Expanding Clinical and Genetic Spectrum of a Treatable Disorder
Brain 133:655-670, Leen,W.G., et al, 2010

NMDA Receptor Encephalitis Mimicking Seronegative Neuromyelitis Optica
Neurol 74:1473-1475, Kruer,M.C., et al, 2010

The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010

Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Characteristic Behavioral and Movement Disorder
Arch Neurol 67:250-251, Ferioli,S.,et al, 2010

Intracerebral and Subarachnoid Hemorrhage in Patients with Cancer
Neurol 74:494-501, Navi,B.B.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

Opsoclonus-Myoclonus Syndrome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Arch Neurol 67:118-121, Kurian,M.,et al, 2010

Positron Emission Tomography-Computed Tomography in Paraneoplastic Neurologic Disorders: Systematic Analysis and Review
Arch Neurol 67:322-329, McKeon,A.,et al, 2010

Subacute sclerosing panencephalitis: An Update
Dev Med Child Neurol 52:901-907, Guitierrez, J.,et al, 2010

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Non-Infectious Endocarditis in a Patient with cANCA-associated Small Vessel Vasculitis
Rheumatology 48:592-594, Horino, T.,et al, 2009

Small Fiber Neuropathy: A Burning Problem
Cleve Clin J Med 76:297-305, Tavee, J. & Zhou, L., 2009

Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

Limbic Encephalitis Associated With Antibodies to the NMDA Receptor in Hodgkin Lymphoma
Neurol 73:2039-2040, Zanid,M.S.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

N-Methyl-D-Aspartate Receptor Antibodies in Pediatric Dyskinetic Encephalitis Lethargica
Ann Neurol 66:704-709, Dale,R.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009



Showing articles 350 to 400 of 6580 << Previous Next >>